# A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBV

> **NCT02751996** · PHASE2 · COMPLETED · sponsor: **F-star Therapeutics, Inc.** · enrollment: 80 (actual)

## Conditions studied

- Hepatitis B
- Hepatitis, Viral

## Interventions

- **DRUG:** SB 9200
- **DRUG:** Placebo
- **DRUG:** Tenofovir

## Key facts

- **NCT ID:** NCT02751996
- **Lead sponsor:** F-star Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2020-02-10
- **Final completion:** 2020-02-10
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2020-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02751996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02751996, "A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBV". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02751996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*